| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.61 | 0.03 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |